Return
TGF-beta inhibitors influence leishmania infection outcome in a susceptible host
S
M
D
P
N
C
B
A
DOI:10.1016/j.cyto.2026.157169.png)
Abstract
En 中文
• TGF-β receptor inhibitor, galunisertib, reduces Leishmania load in macrophages. • Galunisertib enhances nitric oxide production in macrophages. • Galunisertib enhances IFN-γ and TNF-α expression in susceptible BALB/c mice. • Galunisertib reduces splenic and hepatic parasite load in BALB/c mice.
Keywords:
TGF-β inhibitor
Leishmania
macrophages
nitric oxide
IFN-γ
TNF-α
Journal
IF:
3.7
Papers:
9.7K
Citations:
1.4W
